Lymph node (but not spleen) invasion by murine lymphoma is both CD44- and hyaluronate-dependent - PubMed (original) (raw)
. 1995 May 15;154(10):5345-55.
Affiliations
- PMID: 7537306
Lymph node (but not spleen) invasion by murine lymphoma is both CD44- and hyaluronate-dependent
M A Zahalka et al. J Immunol. 1995.
Abstract
Similar to activated T cells, LB T cell lymphoma expresses the CD44 cell surface Ag. In addition, the vast majority of LB cells also express the beta 2 (CD18) and alpha L (CD11a) chains of LFA-1 integrin. In view of the finding that anti-CD18 mAb blocked spleen, but not lymph node invasion by LB cells inoculated s.c. into BALB/c mice, we tested the ability of anti-CD44 mAb (IM 7.8.1) to block the infiltration of LB cells into the lymph nodes. We found that, as opposed to anti-CD18 mAb, anti-CD44 mAb, as well as its F(ab')2 or Fab fragment, prevented lymph node infiltration but had no effect on spleen invasion. This conclusion was based on histologic examination and [3H]thymidine incorporation into proliferating LB cells invading the lymphoid organs. Histologic analysis further demonstrated that LB cells invade the lymph node via the afferent lymphatics. The surface expression of CD44 molecules on LB cells was enhanced after PMA activation. PMA activation also enabled in vitro binding of the lymphoma to hyaluronic acid (HA), a known ligand of CD44. Because anti-CD44 mAb, its F(ab')2 or Fab fragment, and hyaluronidase blocked this binding, we also tested the ability of the enzyme to inhibit lymph node invasion by LB cells. We established through histologic examination and [3H]thymidine incorporation that hyaluronidase protected the lymph node, but not the spleen, from invasion by the lymphoma.
Similar articles
- Involvement of CD44, a molecule with a thousand faces, in cancer dissemination.
Naor D, Wallach-Dayan SB, Zahalka MA, Sionov RV. Naor D, et al. Semin Cancer Biol. 2008 Aug;18(4):260-7. doi: 10.1016/j.semcancer.2008.03.015. Epub 2008 Mar 29. Semin Cancer Biol. 2008. PMID: 18467123 Review. - Apoptosis of T lymphoma cells and its inhibition by monoclonal antibodies against cell surface adhesion molecules.
Tsuruo T, Fujita N, Kataoka S. Tsuruo T, et al. Princess Takamatsu Symp. 1994;24:91-8. Princess Takamatsu Symp. 1994. PMID: 8983066 Review.
Cited by
- Hyaluronic Acid as a Modern Approach in Anticancer Therapy-Review.
Michalczyk M, Humeniuk E, Adamczuk G, Korga-Plewko A. Michalczyk M, et al. Int J Mol Sci. 2022 Dec 21;24(1):103. doi: 10.3390/ijms24010103. Int J Mol Sci. 2022. PMID: 36613567 Free PMC article. Review. - Hyaluronan-based nanocarriers with CD44-overexpressed cancer cell targeting.
Song S, Qi H, Xu J, Guo P, Chen F, Li F, Yang X, Sheng N, Wu Y, Pan W. Song S, et al. Pharm Res. 2014 Nov;31(11):2988-3005. doi: 10.1007/s11095-014-1393-4. Epub 2014 May 20. Pharm Res. 2014. PMID: 24842660 - A novel hyaluronidase produced by Bacillus sp. A50.
Guo X, Shi Y, Sheng J, Wang F. Guo X, et al. PLoS One. 2014 Apr 15;9(4):e94156. doi: 10.1371/journal.pone.0094156. eCollection 2014. PLoS One. 2014. PMID: 24736576 Free PMC article. - Cross-linked hyaluronic acid sub-micron particles: in vitro and in vivo biodistribution study in cancer xenograft model.
Rosso F, Quagliariello V, Tortora C, Di Lazzaro A, Barbarisi A, Iaffaioli RV. Rosso F, et al. J Mater Sci Mater Med. 2013 Jun;24(6):1473-81. doi: 10.1007/s10856-013-4895-4. Epub 2013 Mar 8. J Mater Sci Mater Med. 2013. PMID: 23471500 - Hypotheses on the evolution of hyaluronan: a highly ironic acid.
Csoka AB, Stern R. Csoka AB, et al. Glycobiology. 2013 Apr;23(4):398-411. doi: 10.1093/glycob/cws218. Epub 2013 Jan 12. Glycobiology. 2013. PMID: 23315448 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Miscellaneous